Tumor Necrosis Factor Alpha Blocking Agents as Treatment for Ulcerative Colitis Intolerant or Refractory to Conventional Medical Therapy: A Meta-Analysis-Reference-Cited by-同舟云学术

Tumor Necrosis Factor Alpha Blocking Agents as Treatment for Ulcerative Colitis Intolerant or Refractory to Conventional Medical Therapy: A Meta-Analysis

Published:2014-01-27 Issue:1 Volume:9 Page:e86692
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Lv Ruxi,Qiao Weiguang,Wu Zhiyong,Wang Yinjun,Dai Shixue,Liu Qiang,Zheng Xuebao

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference37 articles.

1. Ulcerative colitis;I Ordas;Lancet,2012

2. Cumulative Incidence and Risk Factors for Hospitalization and Surgery in a Population-based Cohort of Ulcerative Colitis;S Samuel;Inflammatory Bowel Diseases,2013

3. Tumour necrosis factor alpha in stool as a marker of intestinal inflammation;CP Braegger;Lancet,1992

4. Tumour necrosis factor-alpha and interferon-gamma production measured at the single cell level in normal and inflamed human intestine;TT MacDonald;Clinical and Experimental Immunology,1990

5. Serum concentrations of tumour necrosis factor alpha in childhood chronic inflammatory bowel disease;SH Murch;Gut,1991

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Oral Lesions Associated with Systemic Disease;Oral and Maxillofacial Surgery Clinics of North America;2023-05

2. Qingre Xingyu recipe exerts inhibiting effects on ulcerative colitis development by inhibiting TNFα/NLRP3/Caspase-1/IL-1β pathway and macrophage M1 polarization;Cell Death Discovery;2023-03-08

3. Dietary Considerations for Inflammatory Bowel Disease Are Useful for Treatment of Checkpoint Inhibitor-Induced Colitis;Cancers;2022-12-23

4. Efficacy of cytapheresis in patients with ulcerative colitis showing insufficient or lost response to biologic therapy;World Journal of Gastroenterology;2022-09-14

5. Helminth antigens modulate human PBMCs, attenuating disease progression in a humanised mouse model of graft versus host disease;Experimental Parasitology;2022-04